1. Home
  2. MTEN vs AZTR Comparison

MTEN vs AZTR Comparison

Compare MTEN & AZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mingteng International Corporation Inc. Ordinary Shares

MTEN

Mingteng International Corporation Inc. Ordinary Shares

HOLD

Current Price

$1.77

Market Cap

2.2M

Sector

Industrials

ML Signal

HOLD

Logo Azitra Inc

AZTR

Azitra Inc

HOLD

Current Price

$0.21

Market Cap

2.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTEN
AZTR
Founded
2015
2014
Country
China
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
2.2M
IPO Year
2024
2023

Fundamental Metrics

Financial Performance
Metric
MTEN
AZTR
Price
$1.77
$0.21
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
707.6K
2.0M
Earning Date
10-01-2025
02-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,735,337.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.63
N/A
52 Week Low
$1.57
$0.19
52 Week High
$5,206.00
$2.97

Technical Indicators

Market Signals
Indicator
MTEN
AZTR
Relative Strength Index (RSI) 54.97 27.99
Support Level $1.61 $0.19
Resistance Level $1.94 $0.22
Average True Range (ATR) 0.40 0.02
MACD -0.02 -0.00
Stochastic Oscillator 6.40 2.99

Price Performance

Historical Comparison
MTEN
AZTR

About MTEN Mingteng International Corporation Inc. Ordinary Shares

Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

Share on Social Networks: